These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6703685)

  • 1. Mezlocillin pharmacokinetics in pediatric oncology patients.
    Kramer WG; Pickering LK; Culbert S; Frankel LS
    Antimicrob Agents Chemother; 1984 Jan; 25(1):62-4. PubMed ID: 6703685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function.
    Frimodt-Möller N; Maigaard S; Toothaker RD; Bundtzen RW; Brodey MV; Craig WA; Welling PG; Madsen PO
    Antimicrob Agents Chemother; 1980 Apr; 17(4):599-607. PubMed ID: 6446877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dose on pharmacokinetics and serum bactericidal activity of mezlocillin.
    Flaherty JF; Barriere SL; Mordenti J; Gambertoglio JG
    Antimicrob Agents Chemother; 1987 Jun; 31(6):895-8. PubMed ID: 3619421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of mezlocillin in patients with hepatobiliary dysfunction.
    Meyers BR; Srulevitch ES; Sacks HS; Hirschman SZ; Worner TM; Wormser GP; Jacobson J
    J Antimicrob Chemother; 1986 Dec; 18(6):709-13. PubMed ID: 3818496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental pharmacokinetics of mezlocillin in newborn infants.
    Janicke DM; Rubio TT; Wirth FH; Karotkin EH; Jusko WJ
    J Pediatr; 1984 May; 104(5):773-81. PubMed ID: 6716226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of mezlocillin and sulbactam under continuous veno-venous hemodialysis (CVVHD) in intensive care patients with acute renal failure.
    Rohde B; Werner U; Hickstein H; Ehmcke H; Drewelow B
    Eur J Clin Pharmacol; 1997; 53(2):111-5. PubMed ID: 9403281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillin.
    Kampf D; Schurig R; Weihermüller K; Förster D
    Antimicrob Agents Chemother; 1980 Jul; 18(1):81-7. PubMed ID: 6448024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of mezlocillin disposition with a porcine model.
    DiPiro JT; Davis JB; Boudinot FD; Cheung RP; Sisley JF
    Biopharm Drug Dispos; 1989; 10(6):563-72. PubMed ID: 2611357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose pharmacokinetics of ceftibuten (SCH 39720) in infants and children.
    Kearns GL; Reed MD; Jacobs RF; Ardite M; Yogev RD; Blumer JL
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2078-84. PubMed ID: 1759830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic properties of mezlocillin in newborn infants.
    Odio C; Threlkeld N; Thomas ML; McCraken GH
    Antimicrob Agents Chemother; 1984 May; 25(5):556-9. PubMed ID: 6563875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mezlocillin disposition in chronic hemodialysis patients.
    Janicke DM; Mangione A; Schultz RW; Jusko WJ
    Antimicrob Agents Chemother; 1981 Nov; 20(5):590-4. PubMed ID: 6459760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of saturable clearance during high-dose mezlocillin therapy.
    Drusano GL; Forrest A; Fiore D; Auger F; Caplan ES
    Antimicrob Agents Chemother; 1984 Nov; 26(5):686-8. PubMed ID: 6517555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amikacin pharmacokinetics in pediatric patients with malignancy.
    Cleary TG; Pickering LK; Kramer WG; Culbert S; Frankel LS; Kohl S
    Antimicrob Agents Chemother; 1979 Dec; 16(6):829-32. PubMed ID: 533263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics and dosage of mezlocillin administered by intravenous infusion].
    Modr Z; Dvorácek K; Janků I; Krebs V
    Infection; 1982; 10 Suppl 3():S191-5. PubMed ID: 6218111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent pharmacokinetics of mezlocillin in rats.
    Jungbluth GL; Jusko WJ
    Antimicrob Agents Chemother; 1989 Jun; 33(6):839-43. PubMed ID: 2764534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of coadministration on the pharmacokinetics of mezlocillin and cefotaxime in healthy volunteers and in patients with renal failure.
    Rodondi LC; Flaherty JF; Schoenfeld P; Barriere SL; Gambertoglio JG
    Clin Pharmacol Ther; 1989 May; 45(5):527-34. PubMed ID: 2721108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of intravenous mezlocillin in patients with normal and impaired renal function (author's transl)].
    Cano JP; Rigault JP; Gevaudan MJ; Saingra S; Murisasco A; Charpin J
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):335-9. PubMed ID: 6460972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental pharmacokinetics of mezlocillin in 4 newborn infants.
    Jungbluth GL; Wirth FH; Rubio TT; Janicke DM; Jusko WJ
    Dev Pharmacol Ther; 1988; 11(6):317-21. PubMed ID: 3229277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid elimination of quinidine in pediatric patients.
    Szefler SJ; Pieroni DR; Gingell RL; Shen DD
    Pediatrics; 1982 Sep; 70(3):370-5. PubMed ID: 7110810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
    Bonate PL; Cunningham CC; Gaynon P; Jeha S; Kadota R; Lam GN; Razzouk B; Rytting M; Steinherz P; Weitman S
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):875-90. PubMed ID: 20582417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.